Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
'I think the number recruited is closer to 90 in the UK now but will be really slow as hospitalisation is very slow.
I expect they may apply to change the sleeve size.'
@ Deal3r, are you able to provide any reference to this patient recruitment figure? any assistance would ben appreciated if so.
Oakleaf
I think the number recruited is closer to 90 in the UK now but will be really slow as hospitalisation is very slow.
I expect they may apply to change the sleeve size.
I should be surprised that a post telling us we know news is coming in two weeks, posted over five weeks ago with nothing to back it up other than a feeling, should be so well received. While another post about 81 patients, with the author insisting it is from a reliable source, should be met with scepticism.
But I'm not.
I've also seen the "Source Data" I can confirm what Oak has posted is a true reflection of said source data. The caveat of these are numbers taken from multiple sources, throughout the internet and compiled into 1 best guess document also applies.
He’s got a CHIS can’t say to much. Know what I mean or maybe Too much Line of Duty.
Fair enough Matterhorn, seeing as you can disagree but in a civil manner we will call it my guess.
Oak - got to agree with Doc. Let's not throw around numbers if we can't substantiate it. Personally I'll ignore the quoted number and I'll say the following ...
The number you quoted is not impossible, however from 01 - 23 Feb it does require a recruitment rate which is about seven times higher than what both SG016 and Recovery have achieved. We suspect recruitment rates were just below 1% prior to Feb based on an interview with Prof Djukanovic.
Doc, you can stamp your feet, throw your toys and and even change your name to Veruca Salt for all I care.
Hi Joey, can I respectfully ask what are you referring to in your below comment?
Tom W did say there were 15 UK sites in the trial. However whether they were all brought online before cases dropped we not sure :)
Sorry it's not good enough for you Doc but it is what it is. Take it with a pinch of salt for all I care.
I wish I could Matterhorn but it's not my data to disclose but I stand by the source 100%. You are correct those numbers are great and it's easy to see why the belief is that we should easily be passed 200 by now.
Oak - those three alone recruited 81 patients? Wow! Can I ask how you know this? If that's the case it seems the UK might be aiming for the original target of 200 patients which would be great news.
Doc - Re Romania it could just be how their spreadsheet works in that, that particular section only lists the last week's approvals. But, not sure what to make of it really. Doubt it'll be a withdrawal of approval or an error.
Matterhorn, great update. I can add that as of 23rd Feb between Hull, Bournemouth and Southampton they had recruited 81 patients. The other 5 hospitals we just don't know.
Great research Matterhorn
Categorisation is based on official online documents published by each country’s health authority, unless otherwise stated, which raises the possibility that the actual trial status may have progressed from what is stated here.
1) RECRUITING
United Kingdom (estimated 135 – 200 px at 8 sites) *
United States *
Belgium
2) APPROVED
Spain (87px at 11 sites, 19 Mar)
Portugal (50px at 5 sites, 17 Mar)
Italy (41 px at 11 sites, 02 Apr)
France (06 Apr) *
Romania (06 Apr) *
3) PARTIAL APPROVAL
India (88px at 10 sites, 13 Apr) *
4) APPLICATION PENDING
Colombia
Argentina
Brazil
Israel
Mexico
Serbia
5) REMOVED
Germany *
* Notes:
- UK: Prof Wilkinson said there were 15 plus sites in the UK as at 21 Feb, although official records from 03 Mar list eight.
- US: Recruitment based on a tweet showing a screenshot of PharmaTex Research LLC’s recruitment brochure in Amarillo, Tx.
- India: Approval received from Regulator. Approval from five sites outstanding. Trial start date 04 Jun.
- Germany: Removed from list as per latest EU register update for Italy.
- Romania: Most up to date excel file does not contain SG018, but it might just be that the file only contain latest updates for some sections. Not sure.